IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2951
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$199M
Pending
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = FTLF ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 32.9% | 20.5% | 48.8% | 30.6% | 24.4% | 7.7% | 0.9% | 32.0x | $148.6B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.4% | 7.5% | 68.3% | 19.5% | 18.2% | 29.0% | 0.0% | 0.0x | $84M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$FTLF FITLIFE BRANDS, INC. | 44 | 57 | 52 | 38 | 21.1x | 17.1x | 16.3% | 6.2% | 41.7% | 16.0% | 10.2% | 38.7% | 0.0% | 111.0x | $199M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -1.9% | 0.9% | 44.1% | 2.5% | 1.0% | 6.7% | 0.0% | 0.2x | - | REF |
FITLIFE BRANDS, INC. (FTLF) receives a "Reduce" rating with a composite score of 44.1/100. It ranks #2951 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Lagging peers — losers tend to keep underperforming
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for FTLF.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 57 | 56 | +1NEUTRAL |
| MOMENTUM | 38 | 28 | +10ALPHA |
| VALUATION | 52 | 42 | +10ALPHA |
| INVESTMENT | 20 | 2 | +18ALPHA |
| STABILITY | 60 | 58 | +2NEUTRAL |
| SHORT INT | 14 | 0 | +14ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 2.8% vs WACC 7.5% (spread -4.7%)
GM 42% vs sector 44%, OM 16% vs sector 3%
Capital turnover 0.55x
Rev growth 39%, 10yr history
Interest coverage 4.0x, Net debt/EBITDA 17.5x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate FITLIFE BRANDS, INC. (FTLF) as a Reduce with a composite score of 44.1/100 at a current price of $15.08. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential.
FITLIFE BRANDS, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 44.1/100 places it at rank #2951 in our full universe.
Narrow
Medium
Poor
Fair Value
Gross margins of 42% signal strong pricing power.
Returns on equity of 16.3% exceed cost of capital.
Stable competitive position in a defensive sector.
Leverage of 111% D/E amplifies downside risk.
Vulnerability to macroeconomic shocks and interest rate volatility.
FITLIFE BRANDS, INC. represents a reduce based on multi-factor quantitative performance.
FITLIFE BRANDS, INC. receives a Reduce rating from our analysis, with a composite score of 44.1/100 and 2 out of 5 stars, ranking #2951 out of 7,333 stocks. FTLF's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
With a quality score of 57/100, FTLF shows adequate but unremarkable business quality. The company reports a return on equity of 16.3% (sector avg: -1.9%), gross margins of 41.7% (sector avg: 44.1%), net margins of 10.2% (sector avg: 1.0%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
FTLF's value score of 52/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 21.15x, an EV/EBITDA of 17.06x, a P/B ratio of 3.44x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
FITLIFE BRANDS, INC.'s investment score of 20/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 38.7% vs. a sector average of 6.7% and a return on assets of 6.2% (sector: 0.9%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
FTLF is currently showing below-average momentum at 38/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 38.7% year-over-year, while a beta of 0.83 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
With a stability score of 60/100, FTLF exhibits average financial resilience. Key stability metrics include a beta of 0.83 and a debt-to-equity ratio of 111.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
FITLIFE BRANDS, INC.'s short interest score of 14/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 111.00x), micro-cap liquidity risk. At $199M (micro-cap), FTLF carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
FITLIFE BRANDS, INC. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #2951 of 7,333 overall (60th percentile). Key comparisons include ROE of 16.3% exceeding the -1.9% sector median and operating margins of 16.0% above the 2.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While FTLF currently exhibits a REDUCE profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Short Int. (14) would have the largest impact on the composite score.
EV/EBITDA 49% ABOVE SECTOR MEDIAN
ROE 956% BELOW SECTOR MEDIAN
Gross Margin 5% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
FitLife Brands (NASDAQ: FTLF) is a small-cap wellness roll-up at a pivotal moment. With the recent acquisition of Irwin Naturals, the company has a clear path to double revenues and significantly expand margins by applying its e-commerce playbook to Irwin's retail-heavy portfolio.
It hasn't been the best quarter for FitLife Brands, Inc. ( NASDAQ:FTLF ) shareholders, since the share price has fallen...
With a price-to-earnings (or "P/E") ratio of 25.5x FitLife Brands, Inc. ( NASDAQ:FTLF ) may be sending bearish signals...
For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...
OMAHA, NE, Nov. 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2025. Highlights for the third quarter ended September 30, 2025 include: On August 8, 2025, the Company completed the acquisition of substantially all of the assets of Irwin Naturals (“Irwin”), and Irwin’s operating results f